AdvertisementAdvertise with NZME.
Latest from Stock takes
Record highs for US markets: What it means for KiwiSaver investors
KiwiSaver funds have about $35 billion in US equities.
Stock Takes: Why NZ's sharemarket is falling behind global counterparts
The New Zealand sharemarket has fallen 5% in the first half, while others have gained.
AdvertisementAdvertise with NZME.
Stock Takes: 'Unlikely to impact' - analyst downplays Fonterra-Bega legal dispute
Analyst says risks in Fonterra-Bega legal tangle have been overstated.
Stock Takes: Will reporting season see the end of a bear market?
Fisher and Paykel Healthcare will be the main event when it reports on May 28.
Stock Takes: Rain not enough to stop dry weather from hurting NZ power company earnings
Mercury, Meridian and Manawa are likely to be hit hardest by the earlier drought.
Spark auctioning half its data centre business to fund $1b expansion push: report
Surf's up for the telco as its capital-raising effort comes to the sharp end.
Stock Takes: Who’s lining up to buy Fonterra’s Mainland and how much is it worth?
Fonterra's Mainland sale process continues despite a turbulent sharemarket.
Stock Takes: How Sharesies investors responded to ‘Liberation Day ’ convulsions
Sharesies investors have opted to play safe during convulsions on world markets.
What’s next for NZ stocks after a poor first quarter? Stock Takes
New Zealand shares suffered a poor first quarter, driven by sickly corporate earnings.
Stock Takes: Will NZ corporate earnings offer green shoots for the economy?
The reporting season gets fully underway next week. Will there be green shoots?
Stock Takes: Why the NZ sharemarket is lagging the rest
There are some stark contrasts between the local index and other comparable markets.
Stock Takes: Better times ahead for NZX-listed dairy companies?
Synlait is back in action after a terrible 2024, while trade tension overhangs FPH.
Stock Takes: Air NZ banks on loyal fliers for revenue boost
Analysts upgrade airline's rating but are dubious about some of its revenue plans.
Stock Takes: The big issues facing F&P Healthcare
F&P Healthcare's share price has held despite concerns about the US health sector.
Stock Takes: Why a2 is out of favour, and a role reversal for Fonterra
Private equity is seen as a likely buyer for Fonterra's consumer business.
'Money for jam': How much bankers made from Auckland Airport’s whopper capital raise
Plus: Sky TV gets a thumbs-up for its deal-making skills.
Stock Takes: A capital raise for Infratil? Comvita’s mystery bidder
How will Infratil fund its ambitious plans for its Aussie data centre business?
Stock Takes: F&P Healthcare rebounds, tech sector surges and what next for cannabis company?
F&P Healthcare recovers after a sell-off, and what's in store now for Cannasouth.
Stock Takes: Life in the fast lane - the auto stocks bucking NZ’s downtrend
And will new car dealership Armstrong’s try listing on the sharemarket again?